TONIX PHARMACEUTICALS HOLDING CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $33.49M, a 115.74% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $20.13M, a 66.37% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $15.52M, a 44.67% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $59.84M.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for fiscal 2024 was $14.21M.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for fiscal 2017 was $74.00K, a 55.69% decline from fiscal 2016.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for fiscal 2016 was $167.00K, a 4.37% increase from fiscal 2015.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, new issues for fiscal 2015 was $160.00K, a 357.14% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $33.49M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $20.13M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $15.52M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $59.84M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $14.21M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $3.48M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $10.73M 10-Q · filed 2025-11-10 | |
| 2023-09-30 | $6.27M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.03M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $2.00M 10-Q · filed 2024-11-12 | |
| 2020-03-31 | $1.90M 10-Q · filed 2021-11-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $74.00K 10-K · filed 2018-03-09 |
| 2017-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $74.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $64.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $10.00K 10-Q · filed 2017-05-12 | $64.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $167.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $167.00K derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $203.00K derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-03-31 | $113.00K 10-Q · filed 2016-05-06 | $203.00K derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $160.00K 10-K · filed 2017-04-13 |
| 2015-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$40.46M derived: sum of 4 quarters · filed 2016-03-03 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$40.55M derived: sum of 4 quarters · filed 2016-03-03 |
| 2015-03-31 | $70.00K 10-Q · filed 2015-05-08 | -$40.55M derived: sum of 4 quarters · filed 2016-03-03 |
| 2014-12-31 | -$40.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $35.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | |
| 2014-03-31 | $40.65M 10-Q · filed 2014-05-13 | |
| 2012-12-31 | $689.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.63M 10-K · filed 2014-03-28 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | |
| 2012-03-31 | $3.63M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $612.00K 10-K · filed 2014-03-28 | |
| 2010-12-31 | $1.34M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |